Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

SARS-CoV-2 Omicron variant virus isolates are highly sensitive to interferon treatment
Denisa Bojková, Tamara Rothenburger, Sandra Ciesek, et al.
Cell Discovery (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 35

Showing 1-25 of 35 citing articles:

SARS-CoV-2 and innate immunity: the good, the bad, and the “goldilocks”
Benjamín L. Sievers, Mark T. K. Cheng, Kata Csiba, et al.
Cellular and Molecular Immunology (2023) Vol. 21, Iss. 2, pp. 171-183
Open Access | Times Cited: 45
SARS-CoV-2 Exposure in Norway Rats (Rattus norvegicus) from New York City
Yang Wang, Julianna B. Lenoch, D Köhler, et al.
mBio (2023) Vol. 14, Iss. 2
Open Access | Times Cited: 32
Changes in Symptoms Experienced by SARS-CoV-2-Infected Individuals – From the First Wave to the Omicron Variant
Hansjörg Schulze, Wibke Bayer
Frontiers in Virology (2022) Vol. 2
Open Access | Times Cited: 33
Reduced replication but increased interferon resistance of SARS-CoV-2 Omicron BA.1
Rayhane Nchioua, Annika Schundner, Susanne Klute, et al.
Life Science Alliance (2023) Vol. 6, Iss. 6, pp. e202201745-e202201745
Open Access | Times Cited: 21
Identification of novel antiviral drug candidates using an optimized SARS-CoV-2 phenotypic screening platform
Denisa Bojková, Philipp Reus, Leona Panosch, et al.
iScience (2023) Vol. 26, Iss. 2, pp. 105944-105944
Open Access | Times Cited: 16
Mutations accumulated in the Spike of SARS-CoV-2 Omicron allow for more efficient counteraction of the restriction factor BST2/Tetherin
Yuhang Shi, Sydney Simpson, Yuexuan Chen, et al.
PLoS Pathogens (2024) Vol. 20, Iss. 1, pp. e1011912-e1011912
Open Access | Times Cited: 6
BA.1, BA.2 and BA.2.75 variants show comparable replication kinetics, reduced impact on epithelial barrier and elicit cross-neutralizing antibodies
Janmejay Singh, Anbalagan Anantharaj, Aleksha Panwar, et al.
PLoS Pathogens (2023) Vol. 19, Iss. 2, pp. e1011196-e1011196
Open Access | Times Cited: 14
Omicron‐induced interferon signaling prevents influenza A H1N1 and H5N1 virus infection
Denisa Bojková, Marco Bechtel, Tamara Rothenburger, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 3
Open Access | Times Cited: 9
USP22 controls type III interferon signaling and SARS-CoV-2 infection through activation of STING
Rebekka Karlowitz, Megan L. Stanifer, Jens Roedig, et al.
Cell Death and Disease (2022) Vol. 13, Iss. 8
Open Access | Times Cited: 15
SARS-CoV-2 infection of intestinal epithelia cells sensed by RIG-I and DHX-15 evokes innate immune response and immune cross-talk
Lijuan Zhang, Yize Zhang, Ruiqin Wang, et al.
Frontiers in Cellular and Infection Microbiology (2023) Vol. 12
Open Access | Times Cited: 6
SARS-CoV-2 Variants Show Different Host Cell Proteome Profiles With Delayed Immune Response Activation in Omicron-Infected Cells
Melinda Metzler, Rebecca George Tharyan, Kevin Klann, et al.
Molecular & Cellular Proteomics (2023) Vol. 22, Iss. 5, pp. 100537-100537
Open Access | Times Cited: 5
Co-evolution of SARS-CoV-2 variants and host immune response trajectories underlie COVID-19 pandemic to epidemic transition
Ranjeet Maurya, Aparna Swaminathan, Uzma Shamim, et al.
iScience (2023) Vol. 26, Iss. 12, pp. 108336-108336
Open Access | Times Cited: 5
Development of a novel mathematical model that explains SARS-CoV-2 infection dynamics in Caco-2 cells
В. М. Староверов, Stepan Nersisyan, Alexei Galatenko, et al.
PeerJ (2023) Vol. 11, pp. e14828-e14828
Open Access | Times Cited: 4
The nonspecific effects of COVID-19 vaccination upon non-COVID-19 all-cause mortality (NCACM) in the population of England: Effects of age, sex, COVID-19 variant, vaccination history, and time in a real-world study from Jan-21 to May-23
Rod Jones, Andrey Ponomarenko
(2024)
Open Access | Times Cited: 1
Mathematical model explains differences in Omicron and Delta SARS-CoV-2 dynamics in Caco-2 and Calu-3 cells
В. М. Староверов, Alexei Galatenko, E. N. Knyazev, et al.
PeerJ (2024) Vol. 12, pp. e16964-e16964
Open Access | Times Cited: 1
Multiple mechanisms enable broad-spectrum activity of the Pelargonium sidoides root extract EPs 7630 against acute respiratory tract infections
Jindřich Činátl, Mark N. Wass, Martin Michaelis
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 1
Spatiotemporally organized immunomodulatory response to SARS-CoV-2 virus in primary human broncho-alveolar epithelia
Diana Cadena Castaneda, Sonia Jangra, Marina Yurieva, et al.
iScience (2023) Vol. 26, Iss. 8, pp. 107374-107374
Open Access | Times Cited: 4
Synergism of interferon-beta with antiviral drugs against SARS-CoV-2 variants
Denisa Bojková, Richard S. Stack, Tamara Rothenburger, et al.
Journal of Infection (2022) Vol. 85, Iss. 5, pp. 573-607
Open Access | Times Cited: 7
Interferon α-2b spray shortened viral shedding time of SARS-CoV-2 Omicron variant: An open prospective cohort study
Nan Xu, Jinjin Pan, Sun Li, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 5
SARS-CoV-2 exposure in Norway rats (Rattus norvegicus) from New York City
Yang Wang, Julianna B. Lenoch, D Köhler, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 5
Identification of novel antiviral drug candidates using an optimized SARS-CoV-2 phenotypic screening platform
Denisa Bojková, Philipp Reus, Leona Panosch, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 4
The Effective Inhibitory Concentration of Interferon-β Correlates with Infectivity and Replication Fitness of SARS-CoV-2 Variants
Janmejay Singh, Anbalagan Anantharaj, Parveen Kumar, et al.
Journal of Interferon & Cytokine Research (2024) Vol. 44, Iss. 7, pp. 325-333
Closed Access
RNA editing in host lncRNAs as potential modulator in SARS-CoV-2 variants-host immune response dynamics
Partha Chattopadhyay, Priyanka Mehta, Kanika Kanika, et al.
iScience (2024) Vol. 27, Iss. 6, pp. 109846-109846
Open Access
A Phase 3, Randomized, Controlled Trial Evaluating the Efficacy and Safety of Ropeginterferon Alfa-2b in Patients with Moderate COVID-19
Wang-Da Liu, Po‐Hao Feng, Chien‐Yu Cheng, et al.
Infectious Diseases and Therapy (2024) Vol. 13, Iss. 7, pp. 1575-1588
Open Access
Deciphering the molecular nexus between Omicron infection and acute kidney injury: a bioinformatics approach
Li Wang, Anning Chen, Lantian Zhang, et al.
Frontiers in Molecular Biosciences (2024) Vol. 11
Open Access
Page 1 - Next Page

Scroll to top